A comprehensive pan-cancer analysis revealing SPAG6 as a novel diagnostic, prognostic and immunological biomarker in tumor.

Published in: Gland surgery (2024)

influences both the tumor immune infiltration and microenvironment, making it a promising immunotherapeutic target for tumor therapy.

Keyphrases